CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...